Routine surveillance scanning in HNSCC: Lung screening CT scans have value but head and neck scans do not

Objectives: To examine the utility of computed tomography (CT) imaging during routine surveillance for the detection of recurrent head and neck squamous cell carcinoma (HNSCC). Materials/methods: Clinical characteristics of HNSCC patients treated between 2008 and 2017 with radiation therapy or concu...

Full description

Bibliographic Details
Main Authors: Arshad, H. (Author), Degraaff, L. (Author), Duncan, W.D (Author), Gupta, V. (Author), Hicks, W.L., Jr (Author), Iovoli, A.J (Author), Kuriakose, M.A (Author), Platek, A.J (Author), Platek, M.E (Author), Singh, A.K (Author), Wang, C. (Author), Wooten, K.E (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2018
Subjects:
Online Access:View Fulltext in Publisher
LEADER 04473nam a2200973Ia 4500
001 10.1016-j.oraloncology.2018.10.008
008 220706s2018 CNT 000 0 und d
020 |a 13688375 (ISSN) 
245 1 0 |a Routine surveillance scanning in HNSCC: Lung screening CT scans have value but head and neck scans do not 
260 0 |b Elsevier Ltd  |c 2018 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.oraloncology.2018.10.008 
520 3 |a Objectives: To examine the utility of computed tomography (CT) imaging during routine surveillance for the detection of recurrent head and neck squamous cell carcinoma (HNSCC). Materials/methods: Clinical characteristics of HNSCC patients treated between 2008 and 2017 with radiation therapy or concurrent chemoradiation were abstracted from medical records. In patients who achieved a complete response to treatment by positron emission tomography scan, surveillance CT scans were conducted to the maxillofacial area, neck, and chest every 3 months in year 1, every 6 months in year 2, and every 12 months in years 3 and beyond. Results: Within the entire cohort (n = 534), complete response was achieved in 446 patients (83.5%); of these, 84 (15.7%) patients had a recurrence. Among the 84 patients with disease recurrence, 25 (30%) patients remained alive, of which 15 (18%) underwent successful salvage treatment and became free of disease. Lung screening CT scans detected failure in 8 of these successfully salvaged patients. Among the 8 patients successfully salvaged for locoregional recurrence, 3 failures were asymptomatic at onset and detected by laryngoscope or dental exam. The remaining 5 failures were symptomatic and detected upon work up prompted by symptoms. Maxillofacial and neck surveillance CT imaging failed to detect any successfully salvaged patients. Conclusions: Routine surveillance for HNSCC patients with lung CT imaging had value but routine head and neck CT scans failed to identify any successfully salvaged patients. Given this finding, routine CT imaging surveillance in HNSCC patients should be restricted to annual lung screening with low-dose chest CT. © 2018 
650 0 4 |a adult 
650 0 4 |a aged 
650 0 4 |a Aged 
650 0 4 |a Article 
650 0 4 |a cancer patient 
650 0 4 |a cancer radiotherapy 
650 0 4 |a Carcinoma 
650 0 4 |a chemoradiotherapy 
650 0 4 |a Chemoradiotherapy 
650 0 4 |a concurrent chemoradiation 
650 0 4 |a diagnostic imaging 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a follow up 
650 0 4 |a Follow-Up Studies 
650 0 4 |a head 
650 0 4 |a Head 
650 0 4 |a Head and neck neoplasms 
650 0 4 |a Head and Neck Neoplasms 
650 0 4 |a head and neck squamous cell carcinoma 
650 0 4 |a head and neck tumor 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Lung Neoplasms 
650 0 4 |a lung tumor 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a Male 
650 0 4 |a mass screening 
650 0 4 |a Mass Screening 
650 0 4 |a medical record 
650 0 4 |a middle aged 
650 0 4 |a Middle Aged 
650 0 4 |a multimodality cancer therapy 
650 0 4 |a neck 
650 0 4 |a Neck 
650 0 4 |a Neoplasm recurrence 
650 0 4 |a Neoplasm Recurrence, Local 
650 0 4 |a pathology 
650 0 4 |a positron emission tomography 
650 0 4 |a priority journal 
650 0 4 |a procedures 
650 0 4 |a recurrent disease 
650 0 4 |a Retrospective Studies 
650 0 4 |a retrospective study 
650 0 4 |a salvage therapy 
650 0 4 |a Salvage therapy 
650 0 4 |a Salvage Therapy 
650 0 4 |a Squamous cell 
650 0 4 |a Squamous Cell Carcinoma of Head and Neck 
650 0 4 |a thorax radiography 
650 0 4 |a Tomography 
650 0 4 |a Tomography, X-Ray Computed 
650 0 4 |a treatment outcome 
650 0 4 |a Treatment Outcome 
650 0 4 |a treatment response 
650 0 4 |a tumor recurrence 
650 0 4 |a X-ray computed 
650 0 4 |a x-ray computed tomography 
700 1 |a Arshad, H.  |e author 
700 1 |a Degraaff, L.  |e author 
700 1 |a Duncan, W.D.  |e author 
700 1 |a Gupta, V.  |e author 
700 1 |a Hicks, W.L., Jr.  |e author 
700 1 |a Iovoli, A.J.  |e author 
700 1 |a Kuriakose, M.A.  |e author 
700 1 |a Platek, A.J.  |e author 
700 1 |a Platek, M.E.  |e author 
700 1 |a Singh, A.K.  |e author 
700 1 |a Wang, C.  |e author 
700 1 |a Wooten, K.E.  |e author 
773 |t Oral Oncology